- Tytuł:
- A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
- Autorzy:
- Źródło:
-
In
European Journal of Cancer December 2022 177:154-163
Czasopismo naukowe